Michael Thomas Heffernan
Director · Trevi Therapeutics, Inc.
IndividualSelling only8 10b5-1 trades
- 2025
- Sep 17, 2026
- 6
Other insiders active in the same sector
No other insider has filed at Michael Thomas Heffernan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Robert B. Ford - $48.22M in ABT purchases and sales in the last 12 months
- Roger Adsett - $47.51M in INSM purchases and sales in the last 12 months
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
- Matthew Gline - $46.17M in ROIV purchases and sales in the last 12 months
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Thomas Heffernan?
Michael Thomas Heffernan is a corporate insider, tracked as Director of Trevi Therapeutics, Inc. (TRVI). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael Thomas Heffernan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Michael Thomas Heffernan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($596K) across all tracked filings.
